Bank Of New York Mellon Corp Medicinova Inc Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.97 - $2.66 $236,794 - $319,732	120,200 New	120,200 $246,000
Q2 2022 Aug 15, 2022	SELL	$2.31 - $3.14 $1,841 - $2,502	-797 Reduced 0.66%	120,248 $304,000
Q2 2021 Aug 11, 2021	SELL	$3.76 - $5.14 $450,233 - $615,479	-119,743 Reduced 49.73%	121,045 $514,000
Q1 2021 May 13, 2021	SELL	$4.81 - $8.74 $11,760 - $21,369	-2,445 Reduced 1.01%	240,788 $1.22 Million
Q4 2020 Feb 09, 2021	BUY	$5.03 - $6.31 $122,953 - $154,241	24,444 Added 11.17%	243,233 $1.28 Million
Q3 2020 Nov 12, 2020	BUY	$4.67 - $11.0 $143,252 - $337,425	30,675 Added 16.31%	218,789 $1.15 Million
Q2 2020 Aug 12, 2020	BUY	$3.06 - $7.06 $87,773 - $202,509	28,684 Added 17.99%	188,114 $1.02 Million
Q1 2020 May 06, 2020	SELL	$2.9 - $6.97 $324 - $780	-112 Reduced 0.07%	159,430 $593,000
Q4 2019 Feb 14, 2020	BUY	$6.48 - $8.76 $25,349 - $34,269	3,912 Added 2.51%	159,542 $1.08 Million
Q3 2019 Nov 07, 2019	BUY	$7.7 - $10.42 $9,039 - $12,233	1,174 Added 0.76%	155,630 $1.24 Million
Q2 2019 Aug 12, 2019	BUY	$8.29 - $13.22 $10,171 - $16,220	1,227 Added 0.8%	154,456 $1.49 Million
Q1 2019 May 14, 2019	SELL	$6.82 - $10.27 $647 - $975	-95 Reduced 0.06%	153,229 $1.27 Million
Q4 2018 Feb 11, 2019	BUY	$7.65 - $12.83 $4,513 - $7,569	590 Added 0.39%	153,324 $1.25 Million
Q3 2018 Nov 09, 2018	BUY	$7.06 - $12.49 $7,942 - $14,051	1,125 Added 0.74%	152,734 $0
Q2 2018 Aug 06, 2018	BUY	$7.96 - $13.23 $203,409 - $338,079	25,554 Added 20.27%	151,609 $1.21 Million
Q1 2018 May 15, 2018	BUY	$6.6 - $13.91 $127,320 - $268,337	19,291 Added 18.07%	126,055 $1.29 Million
Q4 2017 Feb 09, 2018	BUY	$5.89 - $7.21 $628,839 - $769,768	106,764	106,764 $691,000

Others Institutions Holding MNOV

# of Institutions

Shares Held

4.83M

Call Options Held

9.4K

Put Options Held

View Full List

About MEDICINOVA INC

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $106M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

More about MNOV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account